Diagnosis: Pulmonary M. szulgai infection. Management: Triple drug therapy with rifampicin, ethambutol hydrochloride and clarithromycin. Anti-tumor necrosis factor treatment was continued.

You can access a range of bibliographical databases with your NHS OpenAthens account. Sign in to see what you can access. You can access bibliographic databases from the providers' websites. For ...

HCL Technologies Ltd reported its fiscal second quarter earnings with profit at Rs 4,237 crore. (Image/Reuters) HCL Technologies Ltd on Monday reported its fiscal second quarter earnings with ...

HCL Tech Dividend: HCL Technologies' board of directors announced the issue of an interim dividend for the financial year 2024-25, according to the company's BSE filing on Monday, October 14 ...

HCL Tech is actively working to offset the impact through efficiency measures.

This growth was well distributed across verticals, geographies, and offerings. HCL Software has delivered a stellar performance of 9.4 per cent YoY this quarter and 6.4 per cent growth in H1 FY25 ...

HCL Technologies Ltd (HCL Tech) is likely to post up to 14 per cent year-on-year (YoY) rise in net profit for the September quarter on a single digit growth in sales. Margin is seen improving ...

This is seen a positive cue for Indian IT firms such as Tata Consultancy Services Ltd, Infosys Ltd, HCL Technologies Ltd, Wipro Ltd and Tech Mahindra Ltd. Nuvama said AI has become a key ...